시장보고서
상품코드
1483135

산소포화도측정기 시장 평가 : 제품 유형, 기술 유형, 디바이스 유형, 연령대, 최종사용자, 지역별, 기회, 예측(2017-2031년)

Pulse Oximeter Market Assessment, By Product Type, By Technology Type, By Device Type, By Age-Group, By End-user, By Region, Opportunities and Forecast, 2017-2031F

발행일: | 리서치사: Market Xcel - Markets and Data | 페이지 정보: 영문 220 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    


■ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

세계 산소포화도측정기 시장 규모는 2023년 27억 8,000만 달러에서 2024-2031년 예측 기간 동안 7.33%의 CAGR로 2031년에는 49억 달러 규모로 성장할 것으로 예상됩니다. 이 시장은 최근 몇 년 동안 괄목할 만한 성장세를 보였으며, 앞으로도 강력한 성장세를 유지할 것으로 예상됩니다.

산소포화도측정기 시장은 고령화, 기술 발전, 호흡기 및 심혈관 질환의 유병률 증가, 전반적인 인구 증가 등 여러 가지 요인으로 인해 더욱 확대될 수 있습니다. 업계 대기업과 의료 서비스 제공자는 환자에게 최고의 도구와 솔루션을 제공하기 위해 협력하고 있습니다. 공공 기관과 영리 기업 모두 양질의 솔루션을 제공하기 위해 자금을 조달하고 많은 투자를 하고 있습니다.

호흡기 질환의 유병률 증가:

산소포화도측정기는 만성폐쇄성폐질환(COPD), 천식, 기관내 삽관, 심정지, 수술적 진정, 호흡곤란, 급성호흡곤란증후군(ARDS), 수면장애/수면무호흡증, 청색증성 심장질환의 션트 등 다양한 호흡기 질환에 광범위하게 적용되고 있습니다. 천식은 특히 아시아 중저소득 국가에서 눈에 띄게 증가하고 있습니다. 예를 들어, 2022년 인도의 천식 환자는 3,400만 명으로 추산되며, 이는 전 세계 천식 환자의 13.09%를 차지합니다.

기술의 발전과 쉬운 접근이 시장 성장을 촉진:

산소포화도측정기 시장은 접근성과 사용 편의성을 향상시킨 기술 개발로 인해 급격한 변화를 겪었습니다. 또한, 센서의 소형화가 진행되어 가정이나 이동 중에도 사용할 수 있는 작고 가벼운 산소포화도측정기가 출시되고 있습니다. 이러한 개발로 인해 정확도와 신뢰성이 향상되어 정확한 측정값과 신뢰할 수 있는 결과를 얻을 수 있게 되었습니다. 산소포화도측정기의 실용성과 편의성은 무선 네트워크와 스마트폰 애플리케이션을 통합하여 데이터를 추적, 분석 및 의료 전문가와 공유할 수 있도록함으로써 더욱 향상되었습니다. 이 분야는 또한 AI 알고리즘을 사용하여 맥박 산소 측정 데이터를 결합하여 더 나은 환자 결과와 원격 환자 모니터링에 도움이 되는 등 새로운 기술의 혜택을 누릴 수 있습니다. 예측 기간 동안 자동화, 안전성, 정확성과 관련된 기술 발전은 시장 확대를 촉진할 것으로 예상됩니다.

세계 산소포화도측정기 시장을 조사했으며, 시장 정의와 개요, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 산업 구조, 시장 성장에 영향을 미치는 요인 분석, 사례 연구, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 조사 방법

제2장 프로젝트 범위와 정의

제3장 주요 요약

제4장 세계의 산소포화도측정기 시장 전망

  • 시장 규모와 예측
  • 제품 유형별
    • 휴대용 산소포화도측정기
    • 베드사이드/탁상 산소포화도측정기
  • 기술별
    • 센서
    • 장비
  • 디바이스 유형별
    • 기존 디바이스
    • 커넥티드 디바이스
  • 연령별
    • 성인
    • 소아
  • 최종사용자별
    • 병원
    • 클리닉
    • 재택 케어
    • 외래 센터
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 남미
    • 중동 및 아프리카
  • 기업별 시장 점유율

제5장 세계의 산소포화도측정기 시장 전망 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동 및 아프리카

제6장 시장 매핑, 2023년

  • 제품 유형별
  • 기술별
  • 디바이스 유형별
  • 연령별
  • 최종사용자별
  • 지역별

제7장 거시적 환경과 산업 구조

  • 수급 분석
  • 수출입 분석
  • 밸류체인 분석
  • PESTEL 분석
  • Porter's Five Forces 분석

제8장 시장 역학

  • 성장 촉진요인
  • 성장 저해요인(과제·제약)

제9장 규제 프레임워크와 혁신

  • 특허 상황
  • 혁신/신기술

제10장 주요 기업 상황

  • 시장 리더 상위 5개사 경쟁 매트릭스
  • 시장 리더 상위 5개사 시장 매출 분석
  • M&A·합작투자(해당되는 경우)
  • SWOT 분석(참여 5개사)
  • 특허 분석(해당되는 경우)

제11장 가격 분석

제12장 사례 연구

제13장 주요 기업 전망

  • Medtronic Plc
  • Masimo Corporation
  • Nonin Medical Inc
  • GE HealthCare Technologies, Inc.
  • Contec Medical Systems Co., Ltd.
  • OSI Systems, Inc.
  • Omron Corporation
  • Koninklijke Philips N.V
  • Nihon Kohden Corporation
  • Dragerwerk AG & Co. KGaA
  • ICU Medical

제14장 전략적 제안

제15장 당사 소개와 면책사항

ksm 24.06.03

Global pulse oximeter market is projected to witness a CAGR of 7.33% during the forecast period 2024-2031F, growing from USD 2.78 billion in 2023 to USD 4.9 billion in 2031F. The market has experienced significant growth in recent years and is expected to maintain a strong pace of expansion in the coming years.

A pulse oximeter is a medical device or a non-invasive, discrete tool that monitors blood oxygen saturation fluctuations. It is available in many styles and designs, including fingertip, wrist-worn, bedside/tabletop, and portable oximeters. These styles are commonly used and are always in high demand for their advanced features and ease of carrying. Unlike analog meters, they show additional diagnostic information and oxygen levels by measuring readings using infrared light.

The market for pulse oximeters is anticipated to expand significantly in the upcoming years. This market has the potential to expand even more due to several factors, including an aging population, technology advancements, increased prevalence of respiratory and cardiovascular disorders, and an overall increasing population. Industry giants and healthcare practitioners collaborate to provide patients with the best tools and cosmetic solutions. Both public and commercial organizations are raising money and investing a sizable sum to provide quality solutions. These massive corporations use strategic maneuvers like collaborations, investments, and mergers and acquisitions when they are striving to develop or introduce a new product. For example, in May 2022, Medtronic Plc introduced the Nellcor Oxysoft spO2 sensor, the first pulse oximetry sensor that uses silicon adhesive to protect sensitive skin and improve signal capture and repositionability. Clinicians can make fast judgments for their critically ill patients with the help of this new sensor.

Increasing Prevalence of Respiratory Disorders

Pulse oximeters have a broad range of applications in a variety of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, endotracheal intubation, cardiac arrest, procedural sedation, respiratory complaints, acute respiratory distress syndrome (ARDS), sleep disorders/sleep apnea, and shunts in cyanotic heart disease. A primary factor contributing to the rising need for pulse oximeters in both developed and developing nations is the pervasiveness of long-term respiratory conditions such asthma, COPD, and obstructive sleep apnea (OSA). Instances of asthma are noticeably rising in low- and middle-income nations, especially in Asia. For instance, in 2022, 34 million individuals in India with asthma were anticipated, and they accounted for 13.09% of the worldwide burden. COPD is the third most common cause of death globally, accounting for nearly 3.2 million deaths worldwide. Such factors are expected to expand the market shares of pulse oximetry market.

The market is anticipated to be driven by the rising prevalence of chronic respiratory conditions such cystic fibrosis, asthma, sleep apnea, COPD, and other respiratory infections. Pulse oximeters are a reliable tool for measuring blood oxygen levels in patients with asthma and COPD since oxygen saturation is a crucial criterion in managing these illnesses. With over 12.5 million identified cases and many undiagnosed instances, COPD is the biggest cause of death in the United States, according to an article published by the American Lung Association in 2024. The market for pulse oximeters is expanding due to several factors, one of which is the increased global prevalence of respiratory conditions like pneumonia, asthma, and COPD. People are increasingly realising how crucial it is to keep an eye on their oxygen saturation levels to stay healthy. Additionally, technological developments like mobile applications and wireless connectivity are improving the user experience by providing ease and accessibility to users.

Technological Advancements and Easy Accessibility Drive Market Growth

The market for pulse oximeters has changed dramatically because of technological developments, which have improved accessibility and use. Additionally, introducing small and lightweight pulse oximeters that can be used at home or on the road results from the miniaturization of sensors. These developments have enhanced accuracy and dependability, giving users accurate readings and trustworthy outcomes. The utility and simplicity of pulse oximeters have been further improved by incorporating wireless networking and smartphone applications, which allow for data tracking, analysis, and sharing with healthcare specialists when needed. Pulse oximeters are becoming more widely available to a wider range of consumers due to their improved usability, affordability, and accessibility, propelling the market to uptake these devices. The sector may benefit from emerging technology, such as using artificial intelligence (AI) algorithms to combine pulse oximetry data for better patient outcomes and remote patient monitoring. Technological advances related to automation, safety, and accuracy throughout the projected period are anticipated to propel market expansion. Manufacturers are creating automated, wireless, and remote oximeters for self-monitoring to cut down on hospital stays and doctor visits.

For instance, Smart Meter, a manufacturer, and supplier of patient monitoring devices, launched its iPulseOx in 2022. It offers real-time patient monitoring for long-term conditions and is the first-ever cellular-connected pulse oximeter. This product launch has not only improved the quality of technology in this market but has also given the company a competitive advantage over others in this market.

Increasing Demand for Portable Oximeters Fuels Market Growth

Portable and transportable pulse oximeters are becoming increasingly popular for use in home healthcare. A rise in aging population, combined with their vulnerability to respiratory conditions, is driving expansion in the market. In addition, pulse oximeters come in handy in clinics and hospitals, and their dependency is growing, especially for patients in critical care. Pulse oximeters are being used in aviation and sports medicine because of how compact they are and how quickly they show results. The comfort offered by handheld and wearable oximeters is unparalleled. Easy to carry and manage, these oximeters are lightweight and sleek. The increasing application of pulse oximeters in remote patient monitoring systems is also propelling the market. In addition, the general public's growing emphasis on health and fitness has increased the demand for pulse oximeters. Pulse oximeters are becoming more and more important as tools for athletes, fitness enthusiasts, and those who engage in physical activity to check their oxygen levels while working out. They can enhance their workout performance, avoid overdoing it, and stay safe by continuously checking their oxygen saturation. With the instant feedback that pulse oximeters provide, users can decide on the appropriate level of intensity of their exercise and can make the required modifications. Use of pulse oximeters as vital instruments in the fitness and wellness industry has surged, driving market growth, because of the rising emphasis on maintaining peak fitness levels and prioritising overall well-being.

For example, the Garmin Vivosmart 5 fitness band was introduced in India in June 2022. The new fitness tracker includes features for tracking women's health, heart rate, body battery energy, step count, calorie count, stress, and blood oxygen level.

North America to Dominate the Global Pulse Oximeter Market

North America is anticipated to dominate the global pulse oximeter market and has a sizeable market for smart pulse oximeters because of its improved healthcare infrastructure and the presence of major industry participants. As per the July 2022 report from the Centers for Disease Control and Prevention (CDC), over 805,000 Americans suffer from a heart attack every year. As cardiovascular problems become more common, there will likely be a greater need for pulse oximeters, which will benefit the industry. The market is expanding because of support from regulatory authorities. For example, in June 2023, the Food and Drug Administration (FDA) approved Owlet, a Utah-based healthcare firm, for their baby pulse oximetry featuring its wire-free sock design. BabySat monitors a baby's heart rate and oxygen saturation level using pulse oximetry technology. It notifies carers when a reading deviates from the recommended ranges. Due to the rising prevalence of heart illnesses, which are mostly brought on by sedentary lifestyles and the growing geriatric population in the area, the market is expected to grow profitably for the forecast period.

Future Market Scenario (2024-2031F)

One of the main factors contributing to the anticipated growth of the pulse oximeter market is the increasing population, which will continue to grow in the future, and awareness and desire in people to have the best designs of the most advanced devices in the form of watches or wrist bands. Technology is advancing, and various oximeters are integrated aesthetically into devices like watches and mobiles, so it is a promising factor for this market. Players in this market are expanding at an unparalleled rate, introducing cost-effective and efficient technologies. For instance, Masimo launched MightySat, the first ever FDA-approved over the counter (OTC) fingertip pulse oximeter that can be used without any medical prescription.

Key Players Landscape and Outlook

Several companies, such as Medtronic Plc, Masimo Corporation, Nonin Medical Inc, GE HealthCare Technologies, Inc., Contec Medical Systems Co., Ltd., OSI Systems, Inc., Omron Corporation, Koninklijke Philips N.V, Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, and ICU Medical, are expanding their businesses by planning and adopting new strategies. They are complying with new strategic initiatives regarding the launches of newly developed pulse oximeters, to help researchers and to bring up their presence in the market. New product launches, agreements based on contracts, acquisitions and mergers, investments and partnerships are a few ways through which they are trying to achieve the same.

Collaboration between Masimo Corporation and GE HealthCare Technologies, Inc. to incorporate patient monitoring technology was recently revealed. The goal of the partnership is to incorporate Masimo Signal Extraction Technology (SET) pulse oximetry into GE HealthCare's wearable, wireless patient monitoring system, Portrait Mobile. Cloud-native technology powers Portrait Mobile, an internet of medical things (IoMT) platform. It offers a complete wearable, continuous monitoring experience. In August of this year, Portrait Mobile received FDA approval.

To enhance the treatment of chronic illnesses, Nonin Medical and Medixine have partnered to offer remote patient monitoring for their pulse oximetry devices. The partnership aims to meet the rising need for digital health solutions, especially in the United States. By combining Nonin's pulse oximeters with Medixine's software platform, doctors will have easier patient data access, expediting diagnosis and treatment. The cooperation intends to enhance nightly oximetry tests by digitising healthcare services, perhaps cutting down on months-long procedures to a single night and providing patients with chronic disorders like sleep apnea with more effective care.

Table of Contents

1.Research Methodology

2.Project Scope & Definitions

3.Executive Summary

4.Global Pulse Oximeter Market Outlook, 2017-2031F

  • 4.1.Market Size & Forecast
    • 4.1.1.By Value
    • 4.1.2.By Volume
  • 4.2.By Product Type
    • 4.2.1.Portable Pulse Oximeters
      • 4.2.1.1.Handheld Pulse Oximeters
      • 4.2.1.2.Fingertip Pulse Oximeters
      • 4.2.1.3.Wearable Pulse Oximeters
    • 4.2.2.Bedside/Tabletop Pulse Oximeters
  • 4.3.By Technology Type
    • 4.3.1.Sensors
      • 4.3.1.1.Reusable Sensors
      • 4.3.1.2.Disposable Sensors
    • 4.3.2.Equipments
  • 4.4.By Device Type
    • 4.4.1.Conventional Devices
    • 4.4.2.Connected Devices
  • 4.5.By Age-Group
    • 4.5.1.Adult
    • 4.5.2.Paediatric
      • 4.5.2.1.Infant
      • 4.5.2.2.Neonatal
  • 4.6.By End-user
    • 4.6.1.Hospitals
    • 4.6.2.Clinics
    • 4.6.3.Home-care Settings
    • 4.6.4.Ambulatory Centers
  • 4.7.By Region
    • 4.7.1.North America
    • 4.7.2.Europe
    • 4.7.3.Asia-Pacific
    • 4.7.4.South America
    • 4.7.5.Middle East and Africa
  • 4.8.By Company Market Share (%), 2023

5.Global Pulse Oximeter Market Outlook, By Region, 2017-2031F

  • 5.1.North America*
    • 5.1.1.Market Size & Forecast
      • 5.1.1.1.By Value
      • 5.1.1.2.By Volume
    • 5.1.2.By Product Type
      • 5.1.2.1.Portable Pulse Oximeters
        • 5.1.2.1.1.Handheld Pulse Oximeters
        • 5.1.2.1.2.Fingertip Pulse Oximeters
        • 5.1.2.1.3.Wearable Pulse Oximeters
      • 5.1.2.2.Bedside/Tabletop Pulse Oximeters
    • 5.1.3.By Technology Type
      • 5.1.3.1.Sensors
        • 5.1.3.1.1.Reusable Sensors
        • 5.1.3.1.2.Disposable Sensors
      • 5.1.3.2.Equipments
    • 5.1.4.By Device Type
      • 5.1.4.1.Conventional Devices
      • 5.1.4.2.Connected Devices
    • 5.1.5.By Age-Group
      • 5.1.5.1.Adult
      • 5.1.5.2.Paediatric
        • 5.1.5.2.1.Infant
        • 5.1.5.2.2.Neonatal
    • 5.1.6.By End-user
      • 5.1.6.1.Hospitals
      • 5.1.6.2.Clinics
      • 5.1.6.3.Home-care Settings
      • 5.1.6.4.Ambulatory Centers
    • 5.1.7.United States*
      • 5.1.7.1.Market Size & Forecast
        • 5.1.7.1.1.By Value
        • 5.1.7.1.2.By Volume
      • 5.1.7.2.By Product Type
        • 5.1.7.2.1.Portable Pulse Oximeters
          • 5.1.7.2.1.1.Handheld Pulse Oximeters
          • 5.1.7.2.1.2.Fingertip Pulse Oximeters
          • 5.1.7.2.1.3.Wearable Pulse Oximeters
        • 5.1.7.2.2.Bedside/Tabletop Pulse Oximeters
      • 5.1.7.3.By Technology Type
        • 5.1.7.3.1.Sensors
          • 5.1.7.3.1.1.Reusable Sensors
          • 5.1.7.3.1.2.Disposable Sensors
        • 5.1.7.3.2.Equipments
      • 5.1.7.4.By Device Type
        • 5.1.7.4.1.Conventional Devices
        • 5.1.7.4.2.Connected Devices
      • 5.1.7.5.By Age-Group
        • 5.1.7.5.1.Adult
        • 5.1.7.5.2.Paediatric
          • 5.1.7.5.2.1.Infant
          • 5.1.7.5.2.2.Neonatal
      • 5.1.7.6.By End-user
        • 5.1.7.6.1.Hospitals
        • 5.1.7.6.2.Clinics
        • 5.1.7.6.3.Home-care Settings
        • 5.1.7.6.4.Ambulatory Centers
    • 5.1.8.Canada
    • 5.1.9.Mexico

All segments will be provided for all regions and countries covered

  • 5.2.Europe
    • 5.2.1.Germany
    • 5.2.2.France
    • 5.2.3.Italy
    • 5.2.4.United Kingdom
    • 5.2.5.Russia
    • 5.2.6.Netherlands
    • 5.2.7.Spain
    • 5.2.8.Turkey
    • 5.2.9.Poland
  • 5.3.Asia-Pacific
    • 5.3.1.India
    • 5.3.2.China
    • 5.3.3.Japan
    • 5.3.4.Australia
    • 5.3.5.Vietnam
    • 5.3.6.South Korea
    • 5.3.7.Indonesia
    • 5.3.8.Philippines
  • 5.4.South America
    • 5.4.1.Brazil
    • 5.4.2.Argentina
  • 5.5.Middle East and Africa
    • 5.5.1.Saudi Arabia
    • 5.5.2.UAE
    • 5.5.3.South Africa

6.Market Mapping, 2023

  • 6.1.By Product Type
  • 6.2.By Technology Type
  • 6.3.By Device Type
  • 6.4.By Age-Group
  • 6.5.By End-user
  • 6.6.By Region

7.Macro Environment and Industry Structure

  • 7.1.Demand Supply Analysis
  • 7.2.Import Export Analysis
  • 7.3.Value Chain Analysis
  • 7.4.PESTEL Analysis
    • 7.4.1.Political Factors
    • 7.4.2.Economic System
    • 7.4.3.Social Implications
    • 7.4.4.Technological Advancements
    • 7.4.5.Environmental Impacts
    • 7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5.Porter's Five Forces Analysis
    • 7.5.1.Supplier Power
    • 7.5.2.Buyer Power
    • 7.5.3.Substitution Threat
    • 7.5.4.Threat From New Entrant
    • 7.5.5.Competitive Rivalry

8.Market Dynamics

  • 8.1.Growth Drivers
  • 8.2.Growth Inhibitors (Challenges and Restraints)

9.Regulatory Framework and Innovation

  • 9.1.Patent Landscape
  • 9.2.Innovations/Emerging Technologies

10.Key Players Landscape

  • 10.1.Competition Matrix of Top Five Market Leaders
  • 10.2.Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3.Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4.SWOT Analysis (For Five Market Players)
  • 10.5.Patent Analysis (If Applicable)

11.Pricing Analysis

12.Case Studies

13.Key Players Outlook

  • 13.1.Medtronic Plc
    • 13.1.1.Company Details
    • 13.1.2.Key Management Personnel
    • 13.1.3.Products and Services
    • 13.1.4.Financials (As reported)
    • 13.1.5.Key Market Focus and Geographical Presence
    • 13.1.6.Recent Developments
  • 13.2.Masimo Corporation
  • 13.3.Nonin Medical Inc
  • 13.4.GE HealthCare Technologies, Inc.
  • 13.5.Contec Medical Systems Co., Ltd.
  • 13.6.OSI Systems, Inc.
  • 13.7.Omron Corporation
  • 13.8.Koninklijke Philips N.V
  • 13.9.Nihon Kohden Corporation
  • 13.10.Dragerwerk AG & Co. KGaA
  • 13.11.ICU Medical

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14.Strategic Recommendations

15.About Us & Disclaimer

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제